These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6271517)

  • 21. Hepatic tumors and oral contraceptives: surgical management.
    Gonzalez F; Marks C
    J Surg Oncol; 1985 Jul; 29(3):193-7. PubMed ID: 3001424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver tumours associated with contraceptive hormonal treatment.
    Van Damme B; Desmet VJ
    Acta Gastroenterol Belg; 1985; 48(4):404-9. PubMed ID: 3008486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma associated with oral contraceptives.
    Menzies-Gow N
    Br J Surg; 1978 May; 65(5):316-7. PubMed ID: 206311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative trials of low-dose combined oral contraceptives.
    Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
    J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic adenoma and focal nodular hyperplasia.
    Shortell CK; Schwartz SI
    Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormonal contraception and focal nodular hyperplasia].
    Wedig MP; Altmann C
    Zentralbl Gynakol; 1991; 113(24):1399-402. PubMed ID: 1667053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].
    Herman P; Machado MA; Volpe P; Pugliese V; Vianna MR; Bacchella T; Machado MC; Pinotti HW
    Rev Hosp Clin Fac Med Sao Paulo; 1994; 49(1):30-3. PubMed ID: 8029613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical data on the use of current oral contraceptives].
    Krymskaia ML; Khomasuridze AG
    Akush Ginekol (Mosk); 1983 Nov; (11):19-22. PubMed ID: 6666790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of hepatic adenomas (HCA) to regress after discontinuance of oral contraceptives. An association with focal nodular hyperplasia (FNH) and uterine leiomyoma.
    Marks WH; Thompson N; Appleman H
    Ann Surg; 1988 Aug; 208(2):190-5. PubMed ID: 2840865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking.
    Kanarkowski R; Tornatore KM; D'Ambrosio R; Gardner MJ; Jusko WJ
    Clin Pharmacol Ther; 1988 Jan; 43(1):23-31. PubMed ID: 3121231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Manuilova IA; Dubnitskaia LV; Korsakov SG
    Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic tumors induced by sex steroids.
    Mays ET; Christopherson W
    Semin Liver Dis; 1984 May; 4(2):147-57. PubMed ID: 6087460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible association of angiosarcoma with oral contraceptive agents.
    Shi EC; Fischer A; Crouch R; Ham JM
    Med J Aust; 1981 May; 1(9):473-4. PubMed ID: 7195976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Liver cell carcinoma associated with oral contraceptives (author's transl)].
    Leclère J; Meot B; Marchal F; Mizrahi R; Collard F; Rauber G; Hartemann P
    Ann Endocrinol (Paris); 1977; 38(6):361-2. PubMed ID: 206178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma coexisting with hepatic adenoma. Incidental discovery after long-term oral contraceptive use.
    Korula J; Yellin A; Kanel G; Campofiori G; Nichols P
    West J Med; 1991 Oct; 155(4):416-8. PubMed ID: 1663298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent.
    Yuzpe AA; Smith RP; Rademaker AW
    Fertil Steril; 1982 Apr; 37(4):508-13. PubMed ID: 7040117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.
    Rooks JB; Ory HW; Ishak KG; Strauss LT; Greenspan JR; Hill AP; Tyler CW
    JAMA; 1979 Aug; 242(7):644-8. PubMed ID: 221698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rupture of multiple hepatic adenoma and oral contraceptive use: a case report.
    Nuzzo G; Coppola R; Magistrelli P; Danza FM; Breda M; Vecchio F; Puglionisi A
    Ital J Surg Sci; 1983; 13(4):303-6. PubMed ID: 6671896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.